000 | 01930 a2200517 4500 | ||
---|---|---|---|
005 | 20250514012017.0 | ||
264 | 0 | _c20011207 | |
008 | 200112s 0 0 eng d | ||
022 | _a0263-6352 | ||
024 | 7 |
_a10.1097/00004872-200110000-00019 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHuang, Y | |
245 | 0 | 0 |
_aRole of AT1 and AT2 receptor subtypes in salt-sensitive hypertension induced by sensory nerve degeneration. _h[electronic resource] |
260 |
_bJournal of hypertension _cOct 2001 |
||
300 |
_a1841-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
650 | 0 | 4 |
_aBenzimidazoles _xpharmacology |
650 | 0 | 4 | _aBiphenyl Compounds |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aCalcitonin Gene-Related Peptide _xantagonists & inhibitors |
650 | 0 | 4 |
_aCapsaicin _xpharmacology |
650 | 0 | 4 |
_aDiuresis _xdrug effects |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 |
_aGanglia, Spinal _xmetabolism |
650 | 0 | 4 |
_aHypertension _xchemically induced |
650 | 0 | 4 |
_aImidazoles _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNatriuresis _xdrug effects |
650 | 0 | 4 |
_aNerve Degeneration _xphysiopathology |
650 | 0 | 4 |
_aPyridines _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 | _aReceptor, Angiotensin, Type 1 |
650 | 0 | 4 | _aReceptor, Angiotensin, Type 2 |
650 | 0 | 4 |
_aReceptors, Angiotensin _xphysiology |
650 | 0 | 4 | _aReference Values |
650 | 0 | 4 |
_aRenin _xblood |
650 | 0 | 4 |
_aSodium, Dietary _xadministration & dosage |
650 | 0 | 4 |
_aTetrazoles _xpharmacology |
700 | 1 | _aWang, D H | |
773 | 0 |
_tJournal of hypertension _gvol. 19 _gno. 10 _gp. 1841-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00004872-200110000-00019 _zAvailable from publisher's website |
999 |
_c11513226 _d11513226 |